Shire D, Bourrié B J, Carillon C, Derocq J M, Dousset P, Dumont X, Jansen F K, Kaghad M, Legoux R, Lelong P
Unité de Chimie Organique, Sanofi Elf Bio Recherches, Labège, France.
Gene. 1990 Sep 14;93(2):183-8. doi: 10.1016/0378-1119(90)90223-e.
To assess the biological activity and pharmacokinetic properties of nonglycosylated ricin A-chain (RA), we have obtained the polypeptide following expression of a synthetic 842-bp RA gene in Escherichia coli. Expression of the gene was carried out using the phage T5 PN25 promoter fused to the E. coli lac operator. The RA polypeptide was synthesized in a completely soluble form and was purified in one step by immunoabsorption. It was shown to be as cytotoxic for a human cell line as both native RA and chemically deglycosylated native RA. Reconstituted whole ricin and an immunotoxin containing the recombinant RA were also biologically active. Immunotoxins made with recombinant and deglycosylated RA had similar clearance rates in vivo showing, after a short period of rapid elimination, stabilities far higher than that of an immunotoxin made with native RA. Our results show that the complete elimination of sugar side chains from the RA is not sufficient to entirely eradicate the rapid initial in vivo clearance of RA-based biologicals.
为了评估去糖基化蓖麻毒素A链(RA)的生物活性和药代动力学特性,我们在大肠杆菌中表达了一个842bp的合成RA基因,随后获得了该多肽。该基因的表达是利用与大肠杆菌乳糖操纵子融合的噬菌体T5 PN25启动子进行的。RA多肽以完全可溶的形式合成,并通过免疫吸附一步纯化。结果表明,它对人细胞系的细胞毒性与天然RA和化学去糖基化的天然RA相当。重组全蓖麻毒素和含重组RA的免疫毒素也具有生物活性。用重组RA和去糖基化RA制成的免疫毒素在体内具有相似的清除率,在经过短时间的快速消除后,其稳定性远高于用天然RA制成的免疫毒素。我们的结果表明,从RA中完全去除糖侧链不足以完全消除基于RA的生物制品在体内的快速初始清除。